Top Stories
The money will fund a pivotal trial of StimCardio's Rhyvive wearable following promising early results.
The company's virtual mental health business saw insurance-covered therapy revenue reach $32.1 million, helping offset a sharp decline in direct-to-consumer sales.
The findings could help refine patient selection and shape the design of future stroke trials.
Oura will work with UC San Diego Health to monitor changes in patients' sleep, heart rate and activity between appointments.
One-man company Mithril developed a proof-of-principle for a bispecific antibody treatment for a rare muscular dystrophy in less than 18 months by using Claude to manage operations.
Conference News
Featured symposium will reveal a new vision for intelligent systems that support surgeon judgment, reduce procedural burden and connect the episode of careWARSAW, Ind., Oct. 29, 2026 /PRNewswire/ -- Z...
Presented at ASRM 2026, the pilot study analyzed 375 days of combined hormone and wearable data, finding that Sleep and Readiness scores tended to be lowest around the LH surge.NEW YORK, Oct. 28, 2026...
DURHAM, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Scipher Medicine (Scipher), a leader in immunology precision medicine, today announced the expected launch of an early physician access program for Pris...
O-Cyte 1 combines CBC testing and reviewable cell images with expandable throughput and service-ready design.DÜSSELDORF, Germany, Oct. 28, 2026 /CNW/ -- As AI-assisted morphology becomes more integrat...
The assay detected tumour DNA at concentrations as low as 2.1 parts per million, and patients who tested positive had significantly shorter relapse-free survival.
